Gael MacLean has been a Consultant Oncoplastic Breast Surgeon since 2014 at Oxford University Hospital NHS Foundation Trust. She is currently the Clinical Lead for Breast Surgery in Oxford, based at the Churchill Hospital.
Gael graduated from King’s College Hospital, University of London, and completed her surgical training at hospitals in London, Reading, Oxford, and during a Fellowship at the Karolinska University Hospital in Stockholm, Sweden.
Gael specializes in breast cancer surgery and is passionate about finding the right operation for each individual patient. She offers a range of therapeutic mammoplasties along with other breast-conserving operations. She offers day-case mastectomies as well as breast reconstructive options and axillary (armpit) surgery.
Gael has published and collaborated on several scientific papers on areas of breast cancer surgery including lymphoedema, diagnosis of lesions of uncertain malignant potential, and therapeutic mammoplasties.
Gael has an educational portfolio and is committed to high surgical standards and believes the key to this is through excellent training of surgeons. She is Honorary Secretary of the Faculty of Surgical Trainers based at the Royal College of Surgeons, whose surgical standards have been adopted by the General Medical Council for the standardization of surgical trainers. She has lectured on surgical training internationally and advises on surgeons returning to training after a break.
- Women in Surgery national conference, 2010. RCS England First prize – poster.
- King’s College Hospital Medical 1999: Glaxo Wellcome prize, Hoechst Roussel Medical Prize, Merry McKendrick Elective Prize.
- Oncoplastic Breast Surgery
- Breast and Axilla Cancer Surgery
- Inverted nipple surgery
- Reconstructive surgery
- Breast uplift (mastopexy)
- Mastectomy (breast removal)
- Breast reconstruction
- Local anesthetic
- Breast reduction
- Areola reduction
- Breast oncology
Publications & affiliations
- Is Mode of Presentation of B3 Breast Core Biopsies (Screen-Detected or Symptomatic) a Distinguishing Factor in the Final Histopathologic Result or Risk of Diagnosis of Malignancy? (August 2013).
- Primary hyperparathyroidism with water clear cell content: The impact of the histological diagnosis on clinical management and outcome(April 2013).
- Is the mode of presentation (screening or symptomatic) a distinguishing factor in the pathology of B3core biopsies? (May 2012).
- UK National survey of Gynaecomastia management(May 2012).
- Association of Breast Surgeons
- Associate Editor – World Journal of Surgery
- British Medical Association
- Faculty of Surgical Trainers – Hon Sec.
- Medical Defence Union